1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Spin-lattice relaxation times (T1; s) of Lac, NAA, Cho, and Cr
Metabolite Control Group (n = 10) Neonatal Encephalopathy Infants (n = 17) P Values Normal/Mild Outcome (n = 10) Severe/Fatal Outcome (n = 7) Control Versus Normal/Mild Outcome Control Versus Severe/Fatal Outcome Normal/Mild Outcome Versus Severe/Fatal Outcome Lac 1.28 (0.44) 1.39 (0.63) 1.28 (0.56) .68 1.00 .72 NAA 1.31 (0.31) 1.27 (0.12) 1.16 (0.14) .52 .26 .09 Cho 1.18 (0.22) 1.13 (0.16) 1.11 (0.18) .62 .53 .78 Cr 1.66 (0.64) 1.27 (1.22–1.39) 1.22 (0.23) .65 .11 .46
Note:—Lac indicates lactate; NAA, N-acetylaspartate; Cho, choline; Cr, creatine. Values are mean (SD) and median (interquartile range) as appropriate.